World's Best Scientists 2026 revealed!
Andrew V. Kossenkov

Andrew V. Kossenkov

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
19506
World Ranking
5077
National Ranking
2431

Andrew V. Kossenkov publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Andrew V. Kossenkov sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 624 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Andrew V. Kossenkov D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew V. Kossenkov sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Andrew V. Kossenkov is affiliated with The Wistar Institute in the United States. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. Within these domains, Kossenkov has a significant focus on Molecular Biology, Immunology, Oncology, Cancer Research, and Pulmonary and Respiratory Medicine.

The scientist's work centers on topics related to the role and behavior of immune cells in cancer, viral-associated cancers and disorders, cancer-related hypoxia and metabolism, RNA modifications, immune cell function and interaction, HIV research, as well as epigenetics and DNA methylation.

Recent publications by Andrew V. Kossenkov include the following papers:

  • "Ferroptosis of tumour neutrophils causes immune suppression in cancer," 2022, Nature
  • "Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice," 2021, The Journal of Experimental Medicine
  • "The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer," 2022, Science Immunology
  • "Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils," 2020, Science Translational Medicine
  • "Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts," 2021, Nature Genetics

Frequent coauthors collaborating with Kossenkov include Qin Liu, Toshitha Kannan, Hsin-Yao Tang, Rugang Zhang, and David W. Speicher.

Kossenkov's research has been published predominantly in specialized and high-impact venues including:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Nature
  • PLoS Pathogens

Best Publications

  • Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients

    Thomas Condamine;George A. Dominguez;Je-In Youn;Andrew V. Kossenkov

  • Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A -mutated cancers

    Benjamin G. Bitler;Katherine M. Aird;Azat Garipov;Hua Li

  • Fatty acid transport protein 2 reprograms neutrophils in cancer

    Filippo Veglia;Vladimir A. Tyurin;Maria Blasi;Alessandra De Leo

  • BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.

    Hengrui Zhu;Fee Bengsch;Nikolaos Svoronos;Melanie R. Rutkowski

  • IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity

    Minkyung Song;Tito A. Sandoval;Chang-Suk Chae;Sahil Chopra

  • sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

    Amanpreet Kaur;Amanpreet Kaur;Marie R. Webster;Katie Marchbank;Reeti Behera

  • Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility

    Amanpreet Kaur;Amanpreet Kaur;Amanpreet Kaur;Brett L. Ecker;Stephen M. Douglass;Curtis H. Kugel

  • NAD+ metabolism governs the proinflammatory senescence-associated secretome

    Timothy Nacarelli;Lena Lau;Takeshi Fukumoto;Joseph Zundell

  • Unlinking an lncRNA from Its Associated cis Element

    Vikram R. Paralkar;Cristian C. Taborda;Peng Huang;Yu Yao

  • ARID1A -mutated ovarian cancers depend on HDAC6 activity

    Benjamin G. Bitler;Shuai Wu;Pyoung Hwa Park;Yang Hai

  • PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion

    M. Cecilia Caino;Jagadish C. Ghosh;Young Chan Chae;Valentina Vaira

  • Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology.

    Xuanmao Jiao;Omar Nawab;Tejal Patel;Andrew V. Kossenkov

  • ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression.

    Feven Tameire;Ioannis I Verginadis;Nektaria Maria Leli;Christine Polte

  • Naïve Bayes for microRNA target predictions—machine learning for microRNA targets

    Malik Yousef;Segun Jung;Andrew V. Kossenkov;Louise C. Showe

  • Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming

    Young Chan Chae;Valentina Vaira;Valentina Vaira;M. Cecilia Caino;Hsin Yao Tang

  • Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.

    Michael K. Showe;Anil Vachani;Andrew V. Kossenkov;Malik Yousef

  • Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development.

    Vikram R. Paralkar;Tejaswini Mishra;Jing Luan;Yu Yao

  • Unique pattern of neutrophil migration and function during tumor progression.

    Sima Patel;Sima Patel;Shuyu Fu;Shuyu Fu;Jerome Mastio;George A Dominguez

  • Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice

    Filippo Veglia;Ayumi Hashimoto;Harsh Dweep;Emilio Sanseviero

  • Landscape of the mitochondrial Hsp90 metabolome in tumours.

    Young Chan Chae;Alessia Angelin;Sofia Lisanti;Andrew V. Kossenkov

Frequent Co-Authors

Louise C. Showe
Louise C. Showe The Wistar Institute
David W. Speicher
David W. Speicher The Wistar Institute
Lucia R. Languino
Lucia R. Languino Thomas Jefferson University
Rugang Zhang
Rugang Zhang The Wistar Institute
Dario C. Altieri
Dario C. Altieri The Wistar Institute
Dmitry I. Gabrilovich
Dmitry I. Gabrilovich AstraZeneca (United Kingdom)
Paul M. Lieberman
Paul M. Lieberman The Wistar Institute
Ashani T. Weeraratna
Ashani T. Weeraratna Johns Hopkins University
Maureen E. Murphy
Maureen E. Murphy The Wistar Institute
Xiaowei Xu
Xiaowei Xu University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry often leads to diverse careers in healthcare, research, and management. Students interested in applied fields can pursue the best online nutrition degree programs, which focus on the science of nutrition and its impacts on health. These programs are ideal for those seeking to work in dietetics, wellness, or food science.

For individuals aiming to move into leadership roles within healthcare systems, cahme accredited mha programs offer rigorous training in healthcare management and administration. Those with advanced interests may consider a doctorate in healthcare management, designed to develop executive-level skills for high-responsibility positions.

Additionally, for nurses or healthcare professionals seeking career advancement without traditional clinical requirements, online dnp programs without clinicals can offer flexible doctoral pathways in leadership, policy, or education. These online degree options give biology and biochemistry graduates specialized knowledge for a competitive edge in today’s expanding healthcare industry.

Best Scientists Citing Andrew V. Kossenkov

Trending Scientists

Recently Published Articles